visitect cd4 advanced disease assay Search Results


visitect cd4 advanced disease lateral flow assay  (Omega Diagnostics)
90
Omega Diagnostics visitect cd4 advanced disease lateral flow assay
Characteristics of study participants in Phase 1.
Visitect Cd4 Advanced Disease Lateral Flow Assay, supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect cd4 advanced disease lateral flow assay/product/Omega Diagnostics
Average 90 stars, based on 1 article reviews
visitect cd4 advanced disease lateral flow assay - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
visitect® cd4 advanced  (Omega Diagnostics)
90
Omega Diagnostics visitect® cd4 advanced
Characteristics of study participants in Phase 1.
Visitect® Cd4 Advanced, supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/visitect® cd4 advanced/product/Omega Diagnostics
Average 90 stars, based on 1 article reviews
visitect® cd4 advanced - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of study participants in Phase 1.

Journal: PLoS ONE

Article Title: Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening

doi: 10.1371/journal.pone.0230453

Figure Lengend Snippet: Characteristics of study participants in Phase 1.

Article Snippet: Developed by the Burnet Institute, the Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (Visitect CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable POC test that offers an estimation of the CD4 protein on the surface of CD4+ T cells, providing a semi-quantitative results at a threshold of 200cells/mm 3 [ ].

Techniques:

Contingency table of Visitect CD4 LFA test results with BD FACScount.

Journal: PLoS ONE

Article Title: Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening

doi: 10.1371/journal.pone.0230453

Figure Lengend Snippet: Contingency table of Visitect CD4 LFA test results with BD FACScount.

Article Snippet: Developed by the Burnet Institute, the Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (Visitect CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable POC test that offers an estimation of the CD4 protein on the surface of CD4+ T cells, providing a semi-quantitative results at a threshold of 200cells/mm 3 [ ].

Techniques:

Diagnostic performance of Visitect CD4 LFA at different CD4 cut-offs of the reference test.

Journal: PLoS ONE

Article Title: Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening

doi: 10.1371/journal.pone.0230453

Figure Lengend Snippet: Diagnostic performance of Visitect CD4 LFA at different CD4 cut-offs of the reference test.

Article Snippet: Developed by the Burnet Institute, the Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (Visitect CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable POC test that offers an estimation of the CD4 protein on the surface of CD4+ T cells, providing a semi-quantitative results at a threshold of 200cells/mm 3 [ ].

Techniques: Diagnostic Assay

Perception of the risk of operator-errors in the Visitect CD4 LFA testing workflow among testers.

Journal: PLoS ONE

Article Title: Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening

doi: 10.1371/journal.pone.0230453

Figure Lengend Snippet: Perception of the risk of operator-errors in the Visitect CD4 LFA testing workflow among testers.

Article Snippet: Developed by the Burnet Institute, the Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (Visitect CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable POC test that offers an estimation of the CD4 protein on the surface of CD4+ T cells, providing a semi-quantitative results at a threshold of 200cells/mm 3 [ ].

Techniques: